1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

TERN
Terns Pharmaceuticals, Inc.US flagNASDAQ Global Select
52.95
USD
-0.02
- -
4.77BMarket Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
1
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
1
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
-1
- -
- -
- -
- -
- Operating Expenses
18
70
37
51
62
103
102
110
+ Selling, General & Admin
4
9
9
20
22
39
32
32
+ Research & Development
15
62
28
31
40
63
70
78
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-18
-70
-37
-50
-62
-103
-102
-110
- Non-Operating (Income) Loss
- -
-1
3
- -
-2
-13
-13
-14
+ Interest Expense, Net
- -
-1
- -
- -
-2
-13
-13
-15
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
1
- -
- -
2
13
13
15
+ Other Non-Op (Income) Loss
- -
- -
3
- -
- -
- -
- -
- -
Pretax Income
-18
-69
-40
-50
-60
-90
-89
-96
- Income Tax Expense (Benefit)
- -
- -
1
1
- -
- -
- -
1
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-18
-69
-41
-50
-60
-90
-89
-96
- Net Extraordinary Losses (Gains)
-1
- -
-1
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
-1
- -
-1
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-17
-68
-40
-50
-60
-90
-89
-96
- Minority Interest
- -
- -
1
- -
- -
- -
- -
- -
Net Income, GAAP
-18
-69
-40
-50
-60
-90
-89
-96
- Preferred Dividends
- -
- -
-11
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-18
-69
-29
-50
-60
-90
-89
-96
EBIT
-18
-70
-37
-50
-62
-103
-102
-110
EBITDA
-18
-70
-37
-49
-61
-102
-101
-110
EBITDA Margin (%)
- -
- -
- -
-4,934.8
- -
- -
- -
- -
EBITA
-18
-70
-37
-50
-62
-103
-102
-110
Gross Margin (%)
- -
- -
- -
100
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
-4,986
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
-5,015.8
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
1
1
1
1
Basic Weighted Avg Shares
24
24
23
23
36
71
80
- -
Basic EPS, GAAP
-0.74
-2.86
-1.29
-2.21
-1.67
-1.27
-1.12
- -
Basic EPS from Cont Ops
-0.75
-2.87
-1.79
-2.21
-1.67
-1.27
-1.12
- -
Diluted Weighted Avg Shares
24
24
23
23
36
71
80
- -
Diluted EPS, GAAP
-0.74
-2.86
-1.29
-2.21
-1.67
-1.27
-1.12
- -
Diluted EPS from Cont Ops
-0.75
-2.87
-1.79
-2.21
-1.67
-1.27
-1.12
- -

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
88
22
91
167
285
267
362
1,024
+ Cash, Cash Equivalents & STI
87
20
75
166
283
263
358
1,019
+ Cash & Cash Equivalents
83
12
75
48
143
80
161
525
+ ST Investments
4
7
- -
118
140
184
197
494
+ Accounts & Notes Receiv
- -
- -
13
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
13
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
2
3
3
1
2
4
4
5
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
1
2
1
1
2
1
2
1
+ Property, Plant & Equip, Net
- -
1
1
1
2
1
1
1
+ Property, Plant & Equip
- -
1
2
2
3
3
3
2
- Accumulated Depreciation
- -
- -
1
1
1
2
2
1
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
1
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
1
- -
- -
- -
- -
- -
- -
Total Assets
89
24
92
168
287
269
364
1,025
+ Payables & Accruals
2
4
7
4
4
5
7
9
+ Accounts Payable
1
2
1
2
2
3
2
2
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
2
7
2
2
3
5
7
+ ST Debt
- -
- -
13
- -
1
1
- -
- -
+ ST Borrowings
- -
- -
13
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
1
1
- -
- -
+ Other ST Liabilities
1
1
2
3
4
6
8
7
+ Deferred Revenue
- -
- -
1
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
1
2
3
4
6
8
7
Total Current Liabilities
2
5
23
7
8
12
16
16
+ LT Debt
- -
- -
- -
- -
1
- -
1
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
1
- -
1
- -
+ Other LT Liabilities
14
15
1
1
1
1
1
2
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
14
14
1
1
1
1
1
2
Total Noncurrent Liabilities
14
15
1
1
2
1
2
2
Total Liabilities
17
20
24
8
10
13
18
19
+ Preferred Equity and Hybrid Capital
95
95
186
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
1
15
343
520
588
768
1,524
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
1
15
343
520
588
768
1,524
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-23
-92
-132
-182
-242
-333
-421
-518
+ Other Equity
- -
- -
- -
- -
-1
- -
- -
- -
Equity Before Minority Interest
72
4
69
160
277
255
346
1,007
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
72
4
69
160
277
255
346
1,007
Total Liabilities & Equity
89
24
92
168
287
269
364
1,025
Shares Outstanding
23
23
23
25
54
65
87
112
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
1
1
1
1
Net Debt
-83
-12
-62
-48
-143
-80
-161
-525
Net Debt to Equity
-114.25
-293.01
-90.35
-29.76
-51.72
-31.3
-46.68
-52.13
Tangible Common Equity Ratio
-25.53
-379.69
-127.25
95.38
96.49
95.1
95.04
98.19
Current Ratio
37.25
4.49
3.98
24.48
33.68
22.39
23.14
62.41
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-18
-69
-41
-50
-60
-90
-89
-96
+ Depreciation & Amortization
- -
- -
- -
1
1
1
1
1
+ Non-Cash Items
- -
1
5
9
11
20
14
14
+ Stock-Based Compensation
- -
1
2
8
11
26
16
13
+ Deferred Income Taxes
- -
- -
1
- -
- -
- -
- -
1
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
3
1
- -
-5
-2
- -
+ Chg in Non-Cash Work Cap
- -
2
5
-1
-1
1
4
- -
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
-2
-1
1
- -
-1
-2
- -
-1
+ Inc (Dec) in Accts Payable
1
3
4
-2
1
4
5
1
+ Inc (Dec) in Other
- -
- -
- -
- -
-1
-1
-1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-18
-66
-30
-42
-49
-67
-70
-82
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
-1
-1
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
-1
-1
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
136
167
42
162
706
+ Increase in Capital Stock
- -
- -
- -
136
167
42
162
706
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
-5
-3
7
-119
-22
-38
-12
-298
+ Dec in LT Investment
2
55
8
47
118
238
158
107
+ Inc in LT Investment
-7
-58
-1
-166
-140
-276
-170
-405
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-5
-4
7
-120
-22
-38
-12
-298
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
17
-13
- -
- -
- -
- -
+ Cash From Debt
- -
- -
17
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
-13
- -
- -
- -
- -
+ Other Financing Activities
100
- -
69
11
- -
- -
2
37
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
100
- -
86
134
167
42
164
744
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
77
-70
62
-27
96
-63
82
363
EBITDA
-18
-70
-37
-49
-61
-102
-101
-110
EBITDA Margin (%)
- -
- -
- -
-4,934.8
- -
- -
- -
- -
Free Cash Flow
-18
-67
-30
-42
-49
-67
-70
-82
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-67
88
-241
-49
-67
-70
-82
Free Cash Flow per Basic Share
-0.76
-2.8
-1.34
-1.86
-1.37
-0.95
-0.88
- -
Price/Free Cash Flow
- -
- -
- -
-3.87
-7.51
-6.87
-6.29
- -
Cash Flow to Net Income
1.02
0.97
0.74
0.83
0.81
0.75
0.79
0.85
Capital Expenditures
- -
-1
-1
- -
- -
- -
- -
- -